Rituximab Treatment for Adult Patients with Focal Segmental Glomerulosclerosis
Rituximab Treatment for Adult Patients with Focal Segmental Glomerulosclerosis is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Rituximab Treatment for Adult Patients with Focal Segmental Glomerulosclerosis have?
Rituximab Treatment for Adult Patients with Focal Segmental Glomerulosclerosis has 28 citations in the OpenAlex counts ScholarIQ stores.
When was Rituximab Treatment for Adult Patients with Focal Segmental Glomerulosclerosis published?
Rituximab Treatment for Adult Patients with Focal Segmental Glomerulosclerosis has 2012 year in the ScholarIQ index.
What is the open-access status of Rituximab Treatment for Adult Patients with Focal Segmental Glomerulosclerosis?
Rituximab Treatment for Adult Patients with Focal Segmental Glomerulosclerosis has bronze oa status in the ScholarIQ index.
What is the DOI of Rituximab Treatment for Adult Patients with Focal Segmental Glomerulosclerosis?
The DOI for Rituximab Treatment for Adult Patients with Focal Segmental Glomerulosclerosis is on the source record.
What is the PMID of Rituximab Treatment for Adult Patients with Focal Segmental Glomerulosclerosis?
The PMID for Rituximab Treatment for Adult Patients with Focal Segmental Glomerulosclerosis is on the source record.
What is the OpenAlex record for Rituximab Treatment for Adult Patients with Focal Segmental Glomerulosclerosis?
The OpenAlex for Rituximab Treatment for Adult Patients with Focal Segmental Glomerulosclerosis is on the source record.